Related Experiment Videos

Methamphetamine-induced dopamine release in the medial frontal cortex of freely moving rats

K Kashihara1, T Hamamura, K Okumura

  • 1Department of Neuropsychiatry, Okayama University Medical School, Japan.

The Japanese Journal of Psychiatry and Neurology
|September 1, 1991
PubMed

Insights

Methamphetamine (MAP) increases dopamine (DA) release in the rat medial frontal cortex. This study observed elevated DA levels and reduced metabolite concentrations following MAP administration.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • Methamphetamine (MAP) is a psychostimulant drug with known effects on dopamine (DA) neurotransmission.
  • Understanding MAP's impact on specific brain regions is crucial for comprehending its neurobiological mechanisms and potential for abuse.
  • The medial frontal cortex plays a role in executive functions, and its dopaminergic regulation is of significant interest.

Purpose of the Study:

  • To investigate the effect of methamphetamine on endogenous dopamine efflux in the medial frontal cortex of rats.
  • To quantify changes in extracellular dopamine and its metabolites in response to MAP administration.

Main Methods:

  • In vivo microdialysis technique was employed in freely moving rats.
  • Methamphetamine (4 mg/kg, i.p.) was administered to assess its impact on neurotransmitter levels.

Main Results:

  • Methamphetamine administration significantly increased extracellular dopamine levels in the medial frontal cortex.
  • A significant decrease in the levels of the dopamine metabolite 3,4-dihydroxyphenylacetic acid was observed.
  • The observed changes in dopamine efflux, while smaller than in the striatum, showed similar temporal patterns.

Conclusions:

  • Methamphetamine enhances dopamine efflux in the medial frontal cortex of rats.
  • These findings contribute to understanding the neurochemical basis of MAP's effects on brain function and behavior.

Related Concept Videos